A Machine Learning Approach Yields a Multiparameter Prognostic Marker in Liver Cancer

Xiaoli Liu; Jilin Lu; Guanxiong Zhang; Junyan Han; Wei Zhou; Huan Chen; Henghui Zhang; Zhiyun Yang

doi:10.1158/2326-6066.CIR-20-0616

AACR Publications

AACR logo

Register
Log in
My Cart

Main menu

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
COVID-19
Webinars
Search More

Search for this keyword

Advanced Search

AACR Publications

User menu

Register
Log in
My Cart

Search

Search for this keyword

Advanced search

Home
About
Articles
For Authors
Alerts
News
- Cancer Discovery News
COVID-19
Webinars
Search More

Search for this keyword

Advanced Search

Research Article

A Machine Learning Approach Yields a Multiparameter Prognostic Marker in Liver Cancer

Xiaoli Liu, Jilin Lu, Guanxiong Zhang, Junyan Han, Wei Zhou, Huan Chen, Henghui Zhang and Zhiyun Yang

Xiaoli Liu

1Center for Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, P.R. China.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Jilin Lu

2Department of General Surgery, Huashan Hospital, Fudan University, Shanghai, P.R. China.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Guanxiong Zhang

3Genecast Precision Medicine Technology Institute, Beijing, P.R. China.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Junyan Han

4Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, P.R. China.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Wei Zhou

3Genecast Precision Medicine Technology Institute, Beijing, P.R. China.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Huan Chen

3Genecast Precision Medicine Technology Institute, Beijing, P.R. China.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: zhhbao@ccmu.edu.cn chenhuansym@163.com yangzhiyun2016@163.com

Henghui Zhang

4Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, P.R. China.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: zhhbao@ccmu.edu.cn chenhuansym@163.com yangzhiyun2016@163.com

Zhiyun Yang

1Center for Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, P.R. China.

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site
For correspondence: zhhbao@ccmu.edu.cn chenhuansym@163.com yangzhiyun2016@163.com

DOI: 10.1158/2326-6066.CIR-20-0616

Article
Figures & Data
Info & Metrics
PDF

Article Figures & Data

Additional Files

Supplementary Data

Supplementary Tables and Figures - Supplementary tables 1-3 and figures 1-15.

PreviousNext

This OnlineFirst version was published on February 3, 2021
doi: 10.1158/2326-6066.CIR-20-0616

Open full page PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for sharing this Cancer Immunology Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following A Machine Learning Approach Yields a Multiparameter Prognostic Marker in Liver Cancer

Message Subject (Your Name) has forwarded a page to you from Cancer Immunology Research

Message Body (Your Name) thought you would be interested in this article in Cancer Immunology Research.

Your Personal Message

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Citation Tools

A Machine Learning Approach Yields a Multiparameter Prognostic Marker in Liver Cancer